StockData
FEEDOTCOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

ENvue Medical, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026
$0.50+0.13 (+34.73%)

Close on Oct 19, 2026

Market cap
$3.08M
P/E (TTM)
–
Dividend yield
–

ENvue Medical, Inc. revenue by segment

By business segment

RevenueTTM Q2 26TTM Q1 26TTM Q4 25TTM Q3 25TTM Q2 25TTM Q1 25TTM Q4 24TTM Q3 24TTM Q2 24TTM Q1 24TTM Q4 23TTM Q3 23% of revenueYoY
Nano Vibronix [Member]$1.08M$1.47M$1.86M$2.18M$2.19M$1.74M$2.56M–––––56.0%-50.7%
ENvue [Member]$847.00K$712.00K$696.00K–––––––––44.0%–
Operating incomeTTM Q2 26TTM Q1 26TTM Q4 25TTM Q3 25TTM Q2 25TTM Q1 25TTM Q4 24TTM Q3 24TTM Q2 24TTM Q1 24TTM Q4 23TTM Q3 23YoY
Corporate Segment [Member]$281.00K$2.53M$3.19M––––––––––
Nano Vibronix [Member]-$2.44M-$3.16M-$3.24M-$4.21M-$4.56M-$2.95M-$3.58M–––––-46.5%
ENvue [Member]-$17.70M-$17.73M-$16.45M––––––––––

By product or service

By region

RevenueTTM Q2 26TTM Q1 26TTM Q4 25TTM Q3 25TTM Q2 25TTM Q1 25TTM Q4 24TTM Q3 24TTM Q2 24TTM Q1 24TTM Q4 23TTM Q3 23% of revenueYoY
United States$1.79M$2.02M$2.51M$2.55M$2.20M$2.53M$2.45M$3.17M$3.27M$2.76M$2.16M$1.02B93.1%-18.5%
Europe [Member]–––$34.00K$34.00K–$17.00K–––$101.00K$43.99M––
Australia––––––––$18.00K$10.00K$19.00K$22.00M––
Other Country [Member]–––$65.99K$54.00K$54.02K$50.00K–––––––
Australia New Zealand [Member]––––––$41.00K–––––––

From the segment and revenue-disaggregation notes of ENvue Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.